Ranka Ler - Concepedia

Author

Ranka Ler

Hennepin County Medical Center

Also Known As

R. Sch ler, Ranka Ler

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Hennepin County Medical Center University of Minnesota Orthopaedic Research Foundation Biostatistical Consulting (United States)ARUP Institute for Clinical and Experimental Pathology

About

Ranka Ler is an author at Hennepin County Medical Center specializing in medicine, epidemiology, and medical laboratory science.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	71
2	Public Health	2	2	55
3	Epidemiology	2	2	55
4	Medical Laboratory Science	2	2	68
5	Biostatistics	1	1	33

Ranka Ler

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Determination of 19 Cardiac Troponin I and T Assay 99th Percentile Values from a Common Presumably Healthy Population Fred S. Apple, Ranka Ler, MaryAnn M Murakami Clinical Chemistry	2012	530
Use of the Centaur TnI-Ultra Assay for Detection of Myocardial Infarction and Adverse Events in Patients Presenting With Symptoms Suggestive of Acute Coronary Syndrome Fred S. Apple, Stephen W. Smith, Lesly A. Pearce, Clinical Chemistry	2008	163
Multiple Biomarker Use for Detection of Adverse Events in Patients Presenting with Symptoms Suggestive of Acute Coronary Syndrome Fred S. Apple, Lesly A. Pearce, Adrine Chung, Clinical Chemistry	2007	98
Analytical Characteristics of Commercial Cardiac Troponin I and T Immunoassays in Serum from Rats, Dogs, and Monkeys with Induced Acute Myocardial Injury Fred S. Apple, MaryAnn M Murakami, Ranka Ler, Clinical Chemistry	2008	91
Specificity of B-Type Natriuretic Peptide Assays: Cross-Reactivity with Different BNP, NT-proBNP, and proBNP Peptides Amy K. Saenger, Olaia Rodríguez‐Fraga, Ranka Ler, Clinical Chemistry	2016	76
Point-of-Care i-STAT Cardiac Troponin I for Assessment of Patients with Symptoms Suggestive of Acute Coronary Syndrome, Fred S. Apple, Ranka Ler, Adrine Chung, Clinical Chemistry	2006	63
Prognostic Value of Serial Changes in High-Sensitivity Cardiac Troponin I and T over 3 Months Using Reference Change Values in Hemodialysis Patients Yader Sandoval, Charles A. Herzog, Sara A. Love, Clinical Chemistry	2016	60
Performance characteristics of the ARCHITECT Galectin-3 assay Sonia L. La’ulu, Fred S. Apple, MaryAnn M Murakami, Clinical Biochemistry Analytical InstrumentationMedicineBioanalysisMass SpectrometryLaboratory Medicine	2012	35
Sex-specific 99th percentiles derived from the AACC Universal Sample Bank for the Roche Gen 5 cTnT assay: Comorbidities and statistical methods influence derivation of reference limits Ian L. Gunsolus, Allan S. Jaffe, Anne Sexter, Clinical Biochemistry Sex-specific 99ThRoche Gen 5Reference LimitsGenetic EpidemiologyReproductive Health	2017	33
Incidence of Undetectable, Measurable, and Increased Cardiac Troponin I Concentrations Above the 99th Percentile Using a High-Sensitivity vs a Contemporary Assay in Patients Presenting to the Emergency Department Sara A. Love, Yader Sandoval, Stephen W. Smith, Clinical Chemistry	2016	32

Page 1